Results 201 to 210 of about 8,200 (237)
Some of the next articles are maybe not open access.

Ahomocysteinemia in molybdenum cofactor deficiency

Neurology, 1998
We report an infant with molybdenum cofactor deficiency (MCD) and a unique clinical presentation of hemiplegia, hypotonia, dystonia, and bilateral basal ganglia changes. Biochemistry revealed absent serum homocysteine, low concentrations of plasma cystine, high levels of urinary S-sulfocysteine and sulfite, and high levels of oxypurines in serum and ...
W D, Graf   +4 more
openaire   +2 more sources

Molybdenum Cofactor Disorders

2013
Molybdenum (Mo) cofactor deficiency (MoCD) is characterized by neonatal seizures, high-pitch crying, convulsions, and abnormal EEG and MRI findings accompanied by rapidly progressing neurodegeneration. In the absence of treatment, patients usually die within the first years of life and show no neurodevelopmental improvement.
Günter Schwarz, Alex Veldman
openaire   +1 more source

Molybdenum cofactor biosynthesis and deficiency

Cellular and Molecular Life Sciences, 2005
The molybdenum cofactor (Moco) forms the active site of all molybdenum (Mo) enzymes, except nitrogenase. Mo enzymes catalyze important redox reactions in global metabolic cycles. Moco consists of Mo covalently bound to one or two dithiolates attached to a unique tricyclic pterin moiety commonly referred to as molybdopterin (MPT). Moco is synthesized by
openaire   +2 more sources

Antenatal diagnosis of molybdenum cofactor deficiency

American Journal of Obstetrics and Gynecology, 1990
Analysis of uncultured chorionic villus material from a woman at risk of fetus with sulfite oxidase deficiency revealed a deficiency of sulfite oxidase. This was confirmed on termination of the pregnancy.
R G, Gray   +7 more
openaire   +2 more sources

Molybdenum cofactor and human disease

Current Opinion in Chemical Biology, 2016
Four molybdenum-dependent enzymes are known in humans, each harboring a pterin-based molybdenum cofactor (Moco) in the active site. They catalyze redox reactions using water as oxygen acceptor or donator. Moco is synthesized by a conserved biosynthetic pathway. Moco deficiency results in a severe inborn error of metabolism causing often early childhood
openaire   +2 more sources

Spherophakia associated with molybdenum cofactor deficiency

American Journal of Medical Genetics, 1997
Molybdenum cofactor deficiency is an autosomal recessive disorder characterized by lack of activity of the enzymes sulfite oxidase, aldehyde oxidase, and xanthine dehydrogenase or oxidase. The clinical manifestations are indistinguishable from those of isolated sulfite oxidase deficiency: craniofacial alterations, intractable neonatal convulsions, very
R, Parini   +8 more
openaire   +2 more sources

The biosynthesis of the molybdenum cofactors

JBIC Journal of Biological Inorganic Chemistry, 2014
The biosynthesis of the molybdenum cofactors (Moco) is an ancient, ubiquitous, and highly conserved pathway leading to the biochemical activation of molybdenum. Moco is the essential component of a group of redox enzymes, which are diverse in terms of their phylogenetic distribution and their architectures, both at the overall level and in their ...
Ralf R, Mendel, Silke, Leimkühler
openaire   +2 more sources

Genetics of molybdenum cofactor deficiency

Human Genetics, 2000
Molybdenum cofactor (MoCo) deficiency leads to a combined deficiency of the molybdoenzymes sulphite oxidase, xanthine dehydrogenase and aldehyde oxidase. Effective therapy is not available for this rare disease, which results in neonatal seizures and other neurological symptoms identical to those of sulphite oxidase deficiency.
openaire   +2 more sources

MOLYBDENUM COFACTOR DEFICIENCY

Journal of Neuropathology and Experimental Neurology, 1998
I. Shendrik   +4 more
  +6 more sources

Biogenesis of Molybdenum Cofactors

Critical Reviews in Microbiology, 1990
S M, Hinton, D, Dean
openaire   +2 more sources

Home - About - Disclaimer - Privacy